Drug or chemical induced diabetes mellitus with other skin ulcer
ICD-10 E09.622 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with other skin ulcer.
E09.622 refers to diabetes mellitus that is induced by drugs or chemicals, leading to complications such as skin ulcers. This condition typically arises from the use of certain medications, such as glucocorticoids or antipsychotics, which can disrupt glucose metabolism and lead to hyperglycemia. Patients may present with symptoms of diabetes, including increased thirst, frequent urination, and fatigue. The presence of skin ulcers indicates a complication of diabetes, often due to poor circulation and neuropathy. Management of this condition involves controlling blood glucose levels through lifestyle modifications, monitoring HbA1c levels, and potentially using insulin therapy or oral hypoglycemic agents. Regular foot care and monitoring for skin integrity are crucial to prevent further complications. The complexity of managing drug-induced diabetes lies in the need to balance the treatment of the underlying condition for which the drug was prescribed while addressing the hyperglycemia and its complications.
Detailed medication history, HbA1c levels, and management plans.
Patients presenting with hyperglycemia after starting new medications.
Ensure clear documentation of the relationship between drug use and diabetes onset.
Detailed descriptions of skin ulcers, treatment plans, and follow-up care.
Patients with diabetic ulcers requiring specialized wound care.
Document the impact of diabetes on skin health and ulcer healing.
Used for follow-up visits for diabetes management.
Document patient's diabetes management plan and any complications.
Endocrinologists should focus on medication adjustments and monitoring.
Medications such as glucocorticoids, thiazide diuretics, and certain antipsychotics are known to induce diabetes by affecting insulin sensitivity and secretion.
